Cocrystal Pharma Inc expected to post a loss of 4  cents a share - Earnings Preview

Cocrystal Pharma

11/03/2022 13:26

* Cocrystal Pharma Inc  COCP.OQ   COCP.O  is expected
to show a
fall in quarterly revenue when it reports  results on March 15
(estimated). 
    * ​Refinitiv's mean analyst estimate for Cocrystal Pharma
Inc is
for a loss of 4 cents per share. For the same quarter last year,
the company reported a loss of 2 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Cocrystal
Pharma
Inc is $4​, above​ its last closing price of $0.51. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2021  -0.04       -0.04      -0.04     Met     0
 Jun. 30 2021  -0.03       -0.03      -0.04     Missed  -14.3
 Mar. 31 2021  -0.05       -0.04      -0.04     Met     11.1​
 Dec. 31 2020              -0.04      -0.02     Beat    50
 ​​Sep.                    -0.05      -0.05     Met     0
 30 2020                                                
 Jun. 30 2020  -0.04       -0.04      -0.07     Missed  -75​
 Mar. 31 2020              -0.08      -0.05     Beat    37.5
 Dec. 31 2019              -0.07      -0.05     Beat    28.6
 This summary was machine generated March 11 at 13:26 GMT.  All
figures in US dollars  unless otherwise stated